Caroline Houillier

Mechanisms and therapeutic implications of hypermutation in gliomas

Mehdi Touat, Yvonne Y. Li, Adam N. Boynton et al. · Nature · 2020 · 702 citations · Full text

Medicine, Molecular Genetics, Oncology +12

<i>IDH1</i> or <i>IDH2</i> mutations predict longer survival and response to temozolomide in low-grade gliomas

Caroline Houillier, X. Wang, Gentian Kaloshi et al. · Neurology · 2010 · 533 citations

Medicine, Molecular Genetics, Oncology +17

Safety and Feasibility of Repeated and Transient Blood–Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma

Ahmed Idbaïh, Michael Canney, Lisa Belin et al. · Clinical Cancer Research · 2019 · 346 citations · Full text

Medicine, Neurology, Oncology +17

Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’ iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network

Carole Soussain, Sylvain Choquet, Marie Blonski et al. · European Journal of Cancer · 2019 · 318 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma

Anna Luisa Di Stefano, Alessandra Fucci, Veroniquè Frattini et al. · Clinical Cancer Research · 2015 · 285 citations

Medicine, Oncology, Pharmacology +17